Clinical Trial Update: Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating intravenous immunoglobulin GC5107 in pediatric patients with primary humoral immunodeficiency is currently active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Humoral Immunodeficiency

Drugs mentioned

• Immune Globulin Intravenous (Human) GC5107 (intravenous immunoglobulin)

Snippet

Sponsor: GC Biopharma Corp | Conditions: Primary Immune Deficiency | Phase 3 | Status: ACTIVE_NOT_RECRUITING